BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17315215)

  • 1. De novo diffuse large B-cell lymphoma with coexpression of CD5 and CD23.
    Gujral S; Jain M; Thorat K; Maru D; Nair CN
    Am J Hematol; 2007 Jul; 82(7):684-5. PubMed ID: 17315215
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry.
    Kaleem Z; White G; Vollmer RT
    Am J Clin Pathol; 2001 Jan; 115(1):136-42. PubMed ID: 11190799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of CD23 and CD40 in primary cutaneous B-cell lymphomas.
    Magro C
    J Cutan Pathol; 2007 Jun; 34(6):461-6. PubMed ID: 17518773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration.
    Carulli G; Stacchini A; Marini A; Ciriello MM; Zucca A; Cannizzo E; Aliberti S; Demurtas A; Novero D; Calcagno L; Callegari T; Petrini M
    Am J Clin Pathol; 2009 Aug; 132(2):186-90; quiz 306. PubMed ID: 19605812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mantle cell lymphoma and related lesions].
    Nakamura S; Seto M
    Rinsho Ketsueki; 1996 May; 37(5):408-11. PubMed ID: 8691585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multiple organ relapse in primary de novo CD5+ diffuse large B cell lymphoma of the bone after a complete response].
    Nakayama S; Akioka T; Yokote T; Hara S; Oka S; Yamane K; Yamano T; Tsuji M; Hanafusa T
    Rinsho Ketsueki; 2004 Feb; 45(2):149-54. PubMed ID: 15045824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
    Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
    Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive primary splenic CD5 positive/Cyclin D1 negative B-cell lymphoma in a patient with chronic hepatitis B virus infection.
    Alagiozian-Angelova V; Xu G; Peace D; Gaitonde S
    Acta Oncol; 2008; 47(8):1613-5. PubMed ID: 18607854
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-Hodgkin lymphoma of the breast.
    Ganjoo K; Advani R; Mariappan MR; McMillan A; Horning S
    Cancer; 2007 Jul; 110(1):25-30. PubMed ID: 17541937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
    Paydas S; Ergin M; Erdogan S; Seydaoglu G
    Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification.
    Ahmad E; Garcia D; Davis BH
    Cytometry; 2002 Feb; 50(1):1-7. PubMed ID: 11857591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow.
    Fuda FS; Karandikar NJ; Chen W
    Am J Clin Pathol; 2009 Nov; 132(5):733-7. PubMed ID: 19846815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lymphoma of the liver--a case report.
    Chawla S; Mishra M; Gondal PK
    Indian J Pathol Microbiol; 2004 Oct; 47(4):533-5. PubMed ID: 16295387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma initially manifesting in the bone marrow.
    Kajiura D; Yamashita Y; Mori N
    Am J Clin Pathol; 2007 May; 127(5):762-9. PubMed ID: 17439835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification.
    Garcia DP; Rooney MT; Ahmad E; Davis BH
    Am J Clin Pathol; 2001 Feb; 115(2):258-65. PubMed ID: 11211615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary B-cell non-Hodgkin's lymphoma the commonest testicular malignancy of the elderly.
    Sen A; Mukherjee B
    Indian J Pathol Microbiol; 2007 Jul; 50(3):600-1. PubMed ID: 17883152
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma.
    Mansoor A; Akbari M; Auer I; Lai R
    Hum Pathol; 2007 May; 38(5):797-802. PubMed ID: 17316759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).
    Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Am J Clin Pathol; 2009 Mar; 131(3):339-46. PubMed ID: 19228640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.